This is the authors' abstract. We don't add key points for this paper.
HIV-infected patients with cancer experienced higher cancer-specific mortality than HIV-uninfected patients, independent of cancer stage or receipt of cancer treatment. The elevation in cancer-specific mortality among HIV-infected patients may be attributable to unmeasured stage or treatment differences as well as a direct relationship between immunosuppression and tumor progression.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Coghill et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: